An observational study of ceftolozane/tazobactam continuous infusion administered in an outpatient setting for exacerbations of cystic fibrosis and non-cystic fibrosis bronchiectasis

Funding Activity

Website
http://blog.wishlist.org.au/successful-research-projects/

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.

Funded Activity Summary

No summary found

Funded Activity Details

Start Date: 01-01-2023

End Date: 01-01-2025

Funding Scheme: Funding Scheme not available

Funder: Merck Company Foundation

Research Topics

ANZSRC Field of Research (FoR)

There are no FoR codes available for this funding activity

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

There are no Other Keywords available for this funding activity